Comparison of ER, PR, HER2 and Ki67 expression by MammaTyper® RT-qPCR and immunohistochemistry (IHC) on needle core biopsies of breast cancer

被引：0
|
作者：
Shaaban, A. [1 ,2 ,3 ]
Badr, N. [4 ,5 ]
Zaakouk, M. [6 ,7 ]
Kearns, D. [8 ]
Kong, A. [9 ]
机构：
[1] Queen Elizabeth Hosp Birmingham, Birmingham, England
[2] Univ Birmingham, Cellular Pathol, Birmingham, England
[3] Inst Canc & Genom Sci, Birmingham, England
[4] Menoufia Univ, Fac Med, Shibin Al Kawm, Egypt
[5] Univ Birmingham, Pathol, Shibin Al Kawm, Egypt
[6] Cairo Natl Canc Inst, Cairo, Egypt
[7] Univ Birmingham, Canc Pathol, Cairo, Egypt
[8] Queen Elizabeth Hosp Birmingham, Cellular Pathol, Birmingham, England
[9] Kings Coll London, Ctr Comprehens Canc, Sch Canc & Pharmaceut Sci, London, England
来源：
EUROPEAN JOURNAL OF CANCER | 2022年 / 175卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
263 (PB-0
引用
收藏
页码：S87 / S88
页数：2
相关论文
共 50 条
  • [1] Comparison of immunohistochemistry and RT-qPCR for assessing ER, PR, HER2, and Ki67 and evaluating subtypes in patients with breast cancer
    Lili Chen
    Yanyang Chen
    Zhongpeng Xie
    Jiao Luo
    Yuefeng Wang
    Jianwen Zhou
    Leilei Huang
    Hongxia Li
    Linhai Wang
    Pei Liu
    Man Shu
    Wenhui Zhang
    Zunfu Ke
    Breast Cancer Research and Treatment, 2022, 194 : 517 - 529
  • [2] Comparison of immunohistochemistry and RT-qPCR for assessing ER, PR, HER2, and Ki67 and evaluating subtypes in patients with breast cancer
    Chen, Lili
    Chen, Yanyang
    Xie, Zhongpeng
    Luo, Jiao
    Wang, Yuefeng
    Zhou, Jianwen
    Huang, Leilei
    Li, Hongxia
    Wang, Linhai
    Liu, Pei
    Shu, Man
    Zhang, Wenhui
    Ke, Zunfu
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 194 (03) : 517 - 529
  • [3] Concordance between ER, PR, Ki67, and HER2-low expression in breast cancer by MammaTyper RT-qPCR and immunohistochemistry: implications for the practising pathologist
    Badr, Nahla M.
    Zaakouk, Mohamed
    Zhang, Qi
    Kearns, Daniel
    Kong, Anthony
    Shaaban, Abeer M.
    HISTOPATHOLOGY, 2024, 85 (03) : 437 - 450
  • [4] Comparison of ESR1, PGR, HER2 and KI67 expression by central IHC and MammaTyper® RT-qPCR kit in the FinHer trial
    Wirtz, Ralph M.
    Kellokumpu-Lehtinen, Pirkko-Liisa
    Isola, Jorma
    Kataja, Vesa
    Bono, Petri
    Turpeenniemi-Hujanen, Taina
    Jyrkkio, Sirkuu
    Sitho, Harri
    Eidt, Sebastian
    Sahin, Ugur
    Joensuu, Heikki
    CANCER RESEARCH, 2015, 75
  • [5] Comparison of RT-qPCR with consensus immunohistochemistry by three pathologists for ER, PR, HER2 and Ki-67 in Chinese breast cancer patients
    Teng, X.
    Li, X.
    Xu, S.
    Zhang, J.
    Hartmann, K.
    Laible, M.
    Hipfel, R.
    Bai, Y.
    Ba, X.
    Wu, Z.
    Wirtz, R. M.
    Liu, S.
    Ugur, S.
    CANCER RESEARCH, 2019, 79 (04)
  • [6] Reliability of preoperative core needle biopsy for determing ER, PR, HER2 status and Ki67 expression in invasive breast cancer
    Lakic, T.
    Ivkovic-Kapicl, T.
    Lovrenski, A.
    Sabo, J. Ilic
    Vuckovic-Hardi, L.
    Jelicic, I.
    VIRCHOWS ARCHIV, 2015, 467 : S52 - S52
  • [7] Employing semi-quantitative methods to classify breast cancer markers (ER, PR, HER2, Ki67) expression, using the RT-qPCR based APIS Breast Cancer Subtyping Kit.
    Gasior, Anna
    Wegscheider, Anne-Sophie
    Paveley, Jack
    Howard, Kimberly Jane
    Harrison, Mathew
    Gough, Leanne
    Gorniak, Joanna
    Rollinson, Sara
    Pounce, Zoe
    Niendorf, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Comparison of the Xpert breast cancer stratifier mRNA assay with central ER, PR, HER2, and Ki67 immunohistochemistry (IHC) for rapid biomarker analysis in developing countries
    Brock, J. E.
    Milner, D. A.
    Ho, K.
    Natalie, W.
    Victor, C.
    Annaliza, R.
    Teresa, B.
    Kathryn, G-F
    Edwin, L. W.
    Jodi, W.
    Wendy, W.
    Michael, B.
    CANCER RESEARCH, 2017, 77
  • [9] Biomarker (ER, PR, Her2 and Ki67) Testing On Core Needle Biopsy Specimens From Primary Breast Cancer - Their Usefulness and Limitations
    Nagaoka, H.
    Takahashi, T.
    Endo, K.
    Sugitani, K.
    Nakagami, K.
    Kim, Y.
    Yoshida, Y.
    Ooki, U.
    Horiguchi, J.
    Takeyoshi, I.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S92 - S92
  • [10] Concordance/discordance rates of HER2, ER, PR, and Ki67 in matched pair samples of primary (PBC) and metastatic breast cancer (MBC) tissues when comparing IHC with MammaTyper® RT-PCR kit
    Wallwiener, Markus
    Hartkopf, Andreas
    Deutsch, Thomas
    Sotiris, Lakis
    Taran, Florin-Andrei
    Trumpp, Andreas
    Wirtz, Ralph
    Schneeweiss, Andreas
    CANCER RESEARCH, 2015, 75
12345